Assessing the impact of gout: validating and understanding outcomes

Research output: ThesisDoctoral ThesisExternal prepared

749 Downloads (Pure)

Abstract

Gout is the most common rheumatic disorder in the world and is characterised by attacks of severe pain, redness and swelling of the joints. Gout patients often have other conditions as well (comorbidity), such as cardiovascular disease. With its unpredictable episodes and chronic damage, gout can have a significant impact on a patient's health, particularly when paired with comorbidity. At the moment, research is limited, possibly because gout is a very treatable disease that is not expected to have an immediate impact on health. This dissertation (I) supports the assumption that both gout and comorbidity have an effect on health (II) quantifies an unexpectedly high disease burden (in terms of physical limitations, quality of life and healthcare costs) and (III) highlights the role of general practitioners in treating patients with gout. As such, this dissertation can serve as a starting point for economic and other assessments of innovative medications or as a starting point for further research in a GP setting.
Original languageEnglish
Awarding Institution
  • Maastricht University
Supervisors/Advisors
  • Boonen, Annelies, Supervisor
  • van der Linden, J.M.J.P., Supervisor
  • de Vries, Frank, Advisor
Award date11 May 2017
Place of PublicationMaastricht
Publisher
Print ISBNs9789402805963
DOIs
Publication statusPublished - 2017

Keywords

  • gout
  • disease burden
  • healthcare costs

Cite this